SAHPRA recalls two batches of Levoneptin gabapentin over impurity levels
The South African Health Products Regulatory Authority has ordered a Class II Type B recall of two batches of Levoneptin gabapentin capsules after retained…
Read the notice →Home / Alerts & Recalls
Recalls, falsified medicines, agency alerts and import holds — with batch numbers.
Showing 1–12 of 12 notices
The South African Health Products Regulatory Authority has ordered a Class II Type B recall of two batches of Levoneptin gabapentin capsules after retained…
Read the notice →The Agence Marocaine du Médicament et des Produits de Santé has ordered a batch recall of Vinrab rabies immunoglobulin after detecting a non-conformity; the…
Read the notice →Cape Verde's Entidade Reguladora Independente da Saúde has suspended marketing and ordered immediate withdrawal of two batches of Azitromicina Alvyx 40 mg/15 ml after…
Read the notice →
The Pharmacy and Poisons Board has identified two falsified batches of Lucentis (ranibizumab) 0.3mg injection in the Kenyan market, with one arrest made and…
Read the notice →The Agence Marocaine du Médicament et des Produits de Santé has recalled two batches of Cardioaspirine 100 mg gastro-resistant tablets after a temperature deviation…
Read the notice →
The Tanzania Medicines and Medical Devices Authority has identified a falsified veterinary vaccine bearing the branding of the Tanzania Veterinary Laboratory Agency, with visible…
Read the notice →Steris Verify Dual Specific Self-Contained Biological Indicators for Steam and ETO (S3060) are being recalled in South Africa by SafMed…
Read the notice →Two lots of the BiCOAG Hemostasis Probe are being recalled in South Africa after Olympus, the original equipment manufacturer, determined…
Read the notice →
South Sudan recalls Duphaston and Navidoxine over quality and falsification concernsSouth Sudan’s Drug and Food Control Authority (DFCA) has ordered…
Read the notice →
SPBC urges Pakistan's pharmaceutical industry to address alleged brand falsification in Somalia, warning that the conduct of individual traders could undermine confidence in legitimate…
Read the notice →Post-marketing surveillance found out-of-specification results in the hypertension medicine; the Class II recall covers four batches of 28-tablet packs, two of which remain in…
Read the notice →The order covers YENISOM Healthcare's entire range rather than named batches, and the agency says the ground is procedural: required entry testing was not…
Read the notice →Independent pharmaceutical news and regulatory intelligence covering Africa.